EXL01
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for EXL01, covering 2024-10-10 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients [Phase 1, Phase 2]